Acute Coronary Syndrome

Atherosclerosis continues to be a major cause of death worldwide despite advancements in patient care and research. In addition to calcific nodules and coronary spasm, plaque erosion or rupture is the primary cause of acute coronary syndromes (ACS). Because of this complexity, ACS management must change to emphasise precision medicine in order to account for changing risk profiles and sex-specific variations[1]. The review emphasises the various causes of ACS, the importance of novel imaging methods and diagnostic tools, and the function of AI in individualised treatment. The updated 2023 European Society of Cardiology guidelines include evidence-based suggestions for patient management and treatment approaches, highlighting chances for improved technology utilisation and personalisation in ACS care[2].